Research progress in Laggera medicinal plants.
- Author:
Chang-Xin ZHOU
1
;
Di-Yao WU
;
Xiang-Ping LI
;
Yi-Hang WU
;
Jun ZHAO
;
Nan DONG
;
Rong-Min YU
;
Wei WEI
;
Qun-Xiong ZHENG
;
Han-Dong SUN
;
Xiao-Jiang HAO
;
Yu ZHAO
Author Information
1. College of Pharmaceutical Science, Zhejiang University, Hangzhou 310031, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Anti-Inflammatory Agents, Non-Steroidal;
pharmacology;
therapeutic use;
Antineoplastic Agents, Phytogenic;
pharmacology;
therapeutic use;
Antiviral Agents;
pharmacology;
therapeutic use;
Flavonoids;
chemistry;
isolation & purification;
therapeutic use;
Humans;
Influenza, Human;
drug therapy;
Molecular Structure;
Parotitis;
drug therapy;
Phytotherapy;
Plants, Medicinal;
chemistry;
Ranunculaceae;
chemistry;
Respiratory Tract Infections;
drug therapy;
Sesquiterpenes;
chemistry;
isolation & purification;
therapeutic use
- From:
China Journal of Chinese Materia Medica
2006;31(14):1133-1140
- CountryChina
- Language:Chinese
-
Abstract:
This paper reviewed the worldwide research progresses of the genus Laggera both on phytochemical and pharmacological work in the past few decades. The main secondary metabolites of this genus are proved to be sesquitepenoids, flavonoids and phenolic acids. Phamacological investigations revealed that the certain extracts of some Laggera species possess significant bioactivities on anti-inflammation, anti-tumor and anti-viral infection. This review afforded the comprehensive description of the active components as to provide useful references to elucidate their historical clinical application on upper respiratory infection, influenza, parotitis, and recurrent herpes viral infection.
